Literature DB >> 14762783

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Hashem B El-Serag1, Thomas Tran, James E Everhart.   

Abstract

BACKGROUND & AIMS: An association between diabetes and chronic liver disease has been reported. However, the temporal relationship between these conditions remains unknown.
METHODS: We identified all patients with a hospital discharge diagnosis of diabetes between 1985 and 1990 using the computerized records of the Department of Veterans Affairs. We randomly assigned 3 patients without diabetes for every patient with diabetes. We excluded patients with concomitant liver disease. The remaining cohort was followed through 2000 for the occurrence of chronic nonalcoholic liver disease (CNLD) and hepatocellular carcinoma (HCC). Hazard rate ratios (HRR) were determined in Cox proportional hazard survival analysis.
RESULTS: The study cohort comprised 173,643 patients with diabetes and 650,620 patients without diabetes. Most were men (98%). Patients with diabetes were older (62 vs. 54 years) than patients without diabetes. The incidence of chronic nonalcoholic liver disease was significantly higher among patients with diabetes (incidence rate: 18.13 vs. 9.55 per 10,000 person-years, respectively, P < 0.0001). Similar results were obtained for HCC (incidence rate: 2.39 vs. 0.87 per 10,000 person-years, respectively, P < 0.0001). Diabetes was associated with an HRR of 1.98 (95% CI: 1.88 to 2.09, P < 0.0001) of CNLD and an HRR of 2.16 (1.86 to 2.52, P < 0.0001) of hepatocellular carcinoma. Diabetes carried the highest risk among patients with longer than 10 years of follow-up.
CONCLUSIONS: Among men with diabetes, the risk of CNLD and HCC is doubled. This increase in risk is independent of alcoholic liver disease, viral hepatitis, or demographic features.

Entities:  

Mesh:

Year:  2004        PMID: 14762783     DOI: 10.1053/j.gastro.2003.10.065

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  350 in total

1.  Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Authors:  Tianlu Chen; Guoxiang Xie; Xiaoying Wang; Jia Fan; Yunping Qiu; Xiaojiao Zheng; Xin Qi; Yu Cao; Mingming Su; Xiaoyan Wang; Lisa X Xu; Yun Yen; Ping Liu; Wei Jia
Journal:  Mol Cell Proteomics       Date:  2011-04-25       Impact factor: 5.911

2.  Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma.

Authors:  Denise M Harnois
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

Review 3.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

4.  Review.

Authors:  Hans L Tillmann
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-06

5.  The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C.

Authors:  Dina Hazem Ziada; Sherif El Saadany; Mohamed Enaba; Medhat Ghazy; Azza Hasan
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

6.  Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver disease.

Authors:  Scott J Cotler; Nissim Hay; Hui Xie; Mei Ling Chen; Pei Zhang Xu; Thomas J Layden; Grace Guzman
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

Review 7.  Managing nonalcoholic fatty liver disease: recommendations for family physicians.

Authors:  Ignazio Grattagliano; Piero Portincasa; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

8.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

9.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

10.  Hepatitis and liver disease knowledge and preventive practices among health workers in Mexico: a cross-sectional study.

Authors:  Noreen Islam; Yvonne N Flores; Paula Ramirez; Roshan Bastani; Jorge Salmerón
Journal:  Int J Public Health       Date:  2013-10-06       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.